Technology & Medicine › Atomic & space age
Cancer chemotherapy
1946 (nitrogen mustard); 1948 (Farber)· Invention or discovery· Germs, drugs & genetics
Well documentedSolid records, physical evidence or scientific consensus.
Cancer chemotherapy uses drugs that kill fast-dividing cells, the first treatment able to reach cancer spread throughout the body.
See it on the Technology & Medicine map →How it works
Doctors had noticed that mustard gas destroyed bone marrow and lymph tissue. In 1942 Yale pharmacologists Louis Goodman and Alfred Gilman secretly gave a related compound, nitrogen mustard, to a lymphoma patient, publishing in 1946. In 1948 Sidney Farber in Boston produced temporary remissions in children with leukemia using aminopterin, which blocks folic acid. By the 1970s drug combinations were curing many children with leukemia and adults with Hodgkin lymphoma, though side effects can be severe.
Why it mattered
It made some cancers curable and others manageable, and remains a mainstay of treatment alongside surgery, radiation and newer immune and targeted drugs.
How we know
Goodman and Gilman's 1946 reports, Farber's 1948 paper in the New England Journal of Medicine, and decades of clinical trial data on survival rates.
Connections (2)
▸Salvarsan, the first 'magic bullet' pioneered the 'chemotherapy' idea behind Cancer chemotherapyWell documented
The connection
Ehrlich coined 'chemotherapy' for chemicals that hit disease while sparing the body, his 'magic bullet'. He aimed first at germs but also tested compounds against tumors in mice. Cancer drugs from the 1940s pursued his goal: find chemicals that harm cancer cells more than healthy ones.
When and how
Frankfurt, 1900s–1910 (Ehrlich); Yale and Boston, 1940s (Goodman, Gilman and Farber).
How we know
Ehrlich's writings use the word 'chemotherapy', and later cancer researchers cited his magic-bullet ideal explicitly.
Debates and open questions
Early cancer drugs were blunt, harming all fast-dividing cells; targeted drugs closer to Ehrlich's ideal, such as imatinib (2001), came much later, and none is a perfect magic bullet.
▸Cancer chemotherapy is increasingly complemented by Cancer immunotherapyWell documented
The connection
Chemotherapy, used since the 1940s, poisons rapidly dividing cells, hitting tumors but also hair, gut and blood cells. Immunotherapy instead unleashes or engineers the immune system to attack cancer. Doctors now often combine them: for advanced lung cancer, a checkpoint drug plus chemotherapy became standard treatment around 2018.
When and how
Sidney Farber's chemotherapy in Boston, 1948; checkpoint drugs from 2011; combinations tested in trials such as KEYNOTE-189 for lung cancer, reported in 2018.
How we know
Randomized trials show combinations extend survival in several cancers; treatment guidelines, such as the US National Comprehensive Cancer Network's, record the shift.
Debates and open questions
Which patients need chemotherapy at all, and whether immunotherapy alone can replace it for some cancers, is being tested in ongoing trials.